• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

假设:传统和新型蛋白激酶 C 同工型的结构域结构统一模型。

Hypothesis: Unifying model of domain architecture for conventional and novel protein kinase C isozymes.

机构信息

Department of Pharmacology, University of California, San Diego, La Jolla, California, USA.

Biomedical Sciences Graduate Program, University of California, La Jolla, California, USA.

出版信息

IUBMB Life. 2020 Dec;72(12):2584-2590. doi: 10.1002/iub.2401. Epub 2020 Nov 9.

DOI:10.1002/iub.2401
PMID:33166426
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8086893/
Abstract

Protein kinase C (PKC) family members are multi-domain proteins whose function is exquisitely tuned by interdomain interactions that control the spatiotemporal dynamics of their signaling. Despite extensive mechanistic studies on this family of enzymes, no structure of a full-length enzyme that includes all domains has been solved. Here, we take into account the biochemical mechanisms that control autoinhibition, the properties of each individual domain, and previous structural studies to propose a unifying model for the general architecture of PKC family members. This model shows how the C2 domains of conventional and novel PKC isozymes, which have different topologies and different positions in the primary structure, can occupy the same position in the tertiary structure of the kinase. This common architecture of conventional and novel PKC isozymes provides a framework for understanding how disease-associated mutations impair PKC function.

摘要

蛋白激酶 C(PKC)家族成员是多结构域蛋白,其功能通过控制信号转导的时空动态的结构域间相互作用来进行精细调节。尽管对该酶家族进行了广泛的机制研究,但尚未解决包含所有结构域的全长酶的结构。在这里,我们考虑了控制自身抑制的生化机制、每个单独结构域的特性以及先前的结构研究,以提出 PKC 家族成员的通用结构的统一模型。该模型展示了具有不同拓扑结构和在一级结构中不同位置的传统和新型 PKC 同工酶的 C2 结构域如何能够占据激酶三级结构中的相同位置。传统和新型 PKC 同工酶的这种通用结构为理解与疾病相关的突变如何损害 PKC 功能提供了一个框架。

相似文献

1
Hypothesis: Unifying model of domain architecture for conventional and novel protein kinase C isozymes.假设:传统和新型蛋白激酶 C 同工型的结构域结构统一模型。
IUBMB Life. 2020 Dec;72(12):2584-2590. doi: 10.1002/iub.2401. Epub 2020 Nov 9.
2
Novel Features of DAG-Activated PKC Isozymes Reveal a Conserved 3-D Architecture.二酰甘油激活的蛋白激酶C同工酶的新特征揭示了一种保守的三维结构。
J Mol Biol. 2016 Jan 16;428(1):121-141. doi: 10.1016/j.jmb.2015.11.001. Epub 2015 Nov 12.
3
Regulation of PKC alpha activity by C1-C2 domain interactions.通过C1-C2结构域相互作用对蛋白激酶Cα活性的调控。
J Biol Chem. 2002 May 3;277(18):15277-85. doi: 10.1074/jbc.M112207200. Epub 2002 Feb 15.
4
C2 domains of protein kinase C isoforms alpha, beta, and gamma: activation parameters and calcium stoichiometries of the membrane-bound state.蛋白激酶C亚型α、β和γ的C2结构域:膜结合状态的激活参数和钙化学计量
Biochemistry. 2002 Sep 24;41(38):11411-24. doi: 10.1021/bi026041k.
5
Crystal structure of the C2 domain from protein kinase C-delta.蛋白激酶C-δ的C2结构域的晶体结构
Structure. 1998 Jul 15;6(7):885-94. doi: 10.1016/s0969-2126(98)00090-2.
6
Interplay of C1 and C2 domains of protein kinase C-alpha in its membrane binding and activation.蛋白激酶C-α的C1和C2结构域在其膜结合与激活过程中的相互作用。
J Biol Chem. 1999 Jul 9;274(28):19852-61. doi: 10.1074/jbc.274.28.19852.
7
Indolactam and benzolactam compounds as new medicinal leads with binding selectivity for C1 domains of protein kinase C isozymes.吲哚内酰胺和苯并内酰胺化合物作为对蛋白激酶C同工酶C1结构域具有结合选择性的新型药用先导物。
Curr Pharm Des. 2004;10(12):1371-85. doi: 10.2174/1381612043384907.
8
Electrostatic and hydrophobic interactions differentially tune membrane binding kinetics of the C2 domain of protein kinase Cα.静电相互作用和疏水相互作用对蛋白激酶 Cα 的 C2 结构域与膜结合动力学的调控存在差异。
J Biol Chem. 2013 Jun 7;288(23):16905-16915. doi: 10.1074/jbc.M113.467456. Epub 2013 Apr 15.
9
Synthesis and binding selectivity of 7- and 15-decylbenzolactone-V8 for the C1 domains of protein kinase C isozymes.7-和15-癸基苯并内酯-V8对蛋白激酶C同工酶C1结构域的合成及结合选择性
Bioorg Med Chem Lett. 2003 Sep 15;13(18):3015-9. doi: 10.1016/s0960-894x(03)00637-1.
10
Membrane binding kinetics of protein kinase C betaII mediated by the C2 domain.由C2结构域介导的蛋白激酶CβII的膜结合动力学
Biochemistry. 2001 Nov 6;40(44):13216-29. doi: 10.1021/bi010761u.

引用本文的文献

1
A PKCη missense mutation enhances Golgi-localized signaling and is associated with recessively inherited familial Alzheimer's disease.蛋白激酶Cη错义突变增强高尔基体定位信号传导,并与隐性遗传的家族性阿尔茨海默病相关。
Sci Signal. 2025 Jul;18(893):eadv0970. doi: 10.1126/scisignal.adv0970. Epub 2025 Jul 1.
2
Protein kinase C eta enhances Golgi-localized signaling and is associated with Alzheimer's disease using a recessive mode of inheritance.蛋白激酶C η增强高尔基体定位信号传导,并通过隐性遗传模式与阿尔茨海默病相关。
medRxiv. 2025 May 14:2025.05.13.25327562. doi: 10.1101/2025.05.13.25327562.
3
Cancer-associated mutations in protein kinase C theta are loss-of-function.蛋白激酶 Cθ中的癌症相关突变是失活突变。
Biochem J. 2024 Jun 19;481(12):759-775. doi: 10.1042/BCJ20240148.
4
Illuminating the druggable genome: Pathways to progress.照亮可药物基因组:前进之路。
Drug Discov Today. 2024 Mar;29(3):103805. doi: 10.1016/j.drudis.2023.103805. Epub 2023 Oct 27.
5
Single-residue mutation in protein kinase C toggles between cancer and neurodegeneration.蛋白激酶 C 中的单个残基突变在癌症和神经退行性变之间转换。
Biochem J. 2023 Aug 30;480(16):1299-1316. doi: 10.1042/BCJ20220397.
6
Mutations in protein kinase Cγ promote spinocerebellar ataxia type 14 by impairing kinase autoinhibition.蛋白激酶 Cγ 的突变通过损害激酶自身抑制作用促进脊髓小脑共济失调 14 型。
Sci Signal. 2022 Sep 27;15(753):eabk1147. doi: 10.1126/scisignal.abk1147.
7
Two Sides of the Same Coin: Protein Kinase C γ in Cancer and Neurodegeneration.同一枚硬币的两面:癌症与神经退行性疾病中的蛋白激酶Cγ
Front Cell Dev Biol. 2022 Jun 21;10:929510. doi: 10.3389/fcell.2022.929510. eCollection 2022.
8
Protein kinase C: release from quarantine by mTORC2.蛋白激酶 C:mTORC2 打破隔离
Trends Biochem Sci. 2022 Jun;47(6):518-530. doi: 10.1016/j.tibs.2022.03.003. Epub 2022 Mar 28.
9
PHLPPing the balance: restoration of protein kinase C in cancer.PHLPP 调节平衡:恢复蛋白激酶 C 在癌症中的作用。
Biochem J. 2021 Jan 29;478(2):341-355. doi: 10.1042/BCJ20190765.

本文引用的文献

1
Protein Kinase C Quality Control by Phosphatase PHLPP1 Unveils Loss-of-Function Mechanism in Cancer.蛋白激酶 C 的质量控制由磷酸酶 PHLPP1 揭示癌症中的失活机制。
Mol Cell. 2019 Apr 18;74(2):378-392.e5. doi: 10.1016/j.molcel.2019.02.018. Epub 2019 Mar 20.
2
Protein kinase C: perfectly balanced.蛋白激酶 C:恰到好处的平衡。
Crit Rev Biochem Mol Biol. 2018 Apr;53(2):208-230. doi: 10.1080/10409238.2018.1442408.
3
: a comprehensive data analysis suite for small-angle scattering from macromolecular solutions.用于大分子溶液小角散射的综合数据分析套件。
J Appl Crystallogr. 2017 Jun 26;50(Pt 4):1212-1225. doi: 10.1107/S1600576717007786. eCollection 2017 Aug 1.
4
3D clusters of somatic mutations in cancer reveal numerous rare mutations as functional targets.癌症中体细胞突变的三维簇揭示了众多作为功能靶点的罕见突变。
Genome Med. 2017 Jan 23;9(1):4. doi: 10.1186/s13073-016-0393-x.
5
The ClusPro web server for protein-protein docking.ClusPro 网页服务器,用于蛋白质-蛋白质对接。
Nat Protoc. 2017 Feb;12(2):255-278. doi: 10.1038/nprot.2016.169. Epub 2017 Jan 12.
6
The Role of Regulatory Domains in Maintaining Autoinhibition in the Multidomain Kinase PKCα.调节结构域在多结构域激酶PKCα维持自身抑制中的作用
J Biol Chem. 2017 Feb 17;292(7):2873-2880. doi: 10.1074/jbc.M116.768457. Epub 2017 Jan 3.
7
Novel Features of DAG-Activated PKC Isozymes Reveal a Conserved 3-D Architecture.二酰甘油激活的蛋白激酶C同工酶的新特征揭示了一种保守的三维结构。
J Mol Biol. 2016 Jan 16;428(1):121-141. doi: 10.1016/j.jmb.2015.11.001. Epub 2015 Nov 12.
8
Intramolecular C2 Domain-Mediated Autoinhibition of Protein Kinase C βII.蛋白激酶CβII的分子内C2结构域介导的自身抑制
Cell Rep. 2015 Aug 25;12(8):1252-60. doi: 10.1016/j.celrep.2015.07.039. Epub 2015 Aug 13.
9
Cancer-associated protein kinase C mutations reveal kinase's role as tumor suppressor.癌症相关的蛋白激酶C突变揭示了该激酶作为肿瘤抑制因子的作用。
Cell. 2015 Jan 29;160(3):489-502. doi: 10.1016/j.cell.2015.01.001. Epub 2015 Jan 22.
10
Molecular mechanism of regulation of the atypical protein kinase C by N-terminal domains and an allosteric small compound.N端结构域和变构小分子对非典型蛋白激酶C的调控分子机制
Chem Biol. 2014 Jun 19;21(6):754-65. doi: 10.1016/j.chembiol.2014.04.007. Epub 2014 May 15.